소 유방염 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Bovine Mastitis Market size is expected to reach USD 5.13 Billion in 2034 from USD 2.42 Billion (2025) growing at a CAGR of 8.69% during 2026-2034.

The bovine mastitis market is gaining traction due to rising awareness of animal health, dairy productivity, and food safety. Mastitis remains a leading cause of economic losses in the dairy industry, driving demand for diagnostics, therapeutics, and preventive solutions. Increased adoption of advanced veterinary practices and herd management systems is accelerating market growth.

Innovation is focused on rapid point-of-care diagnostics, novel antibiotics, and alternative therapies such as probiotics and vaccines. Digital livestock monitoring systems are enabling early detection and better disease management. Integration of automated milking systems with health monitoring tools is further enhancing herd productivity and welfare.

The market outlook is strengthened by rising global dairy consumption, regulatory emphasis on reducing antibiotic residues, and investments in sustainable farming practices. The bovine mastitis market is positioned as a critical component of the animal health sector, supporting both economic and food security objectives.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Pharmaceuticals
• Antibiotics
• Vaccines
• Others
• Diagnostics

By Type

• Clinical Mastitis
• Sub-Clinical Mastitis

By Therapy

• Dry Period
• Lactating Period

By Route Of Administration

• Intra-Mammary
• Systemic

By End-use

• Veterinary Hospitals/Clinics
• Others

COMPANIES PROFILED

• Boehringer Ingelheim Animal Health, Zoetis, Merck Co Inc, Ceva, Elanco, HIPRA, Immucell Corporation, Forte Healthcare Ltd, Virbac, Heilsaa
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BOVINE MASTITIS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Pharmaceuticals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Antibiotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BOVINE MASTITIS MARKET: BY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Type
• 5.2. Clinical Mastitis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Sub-Clinical Mastitis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BOVINE MASTITIS MARKET: BY THERAPY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Therapy
• 6.2. Dry Period Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Lactating Period Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BOVINE MASTITIS MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Route Of Administration
• 7.2. Intra-Mammary Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Systemic Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BOVINE MASTITIS MARKET: BY END-USE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End-use
• 8.2. Veterinary Hospitals/Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL BOVINE MASTITIS MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product
  • 9.2.2 By Type
  • 9.2.3 By Therapy
  • 9.2.4 By Route Of Administration
  • 9.2.5 By End-use
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product
  • 9.3.2 By Type
  • 9.3.3 By Therapy
  • 9.3.4 By Route Of Administration
  • 9.3.5 By End-use
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product
  • 9.4.2 By Type
  • 9.4.3 By Therapy
  • 9.4.4 By Route Of Administration
  • 9.4.5 By End-use
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product
  • 9.5.2 By Type
  • 9.5.3 By Therapy
  • 9.5.4 By Route Of Administration
  • 9.5.5 By End-use
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product
  • 9.6.2 By Type
  • 9.6.3 By Therapy
  • 9.6.4 By Route Of Administration
  • 9.6.5 By End-use
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL BOVINE MASTITIS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Boehringer Ingelheim Animal Health
  • 11.2.2 Zoetis
  • 11.2.3 Merck & Co. Inc
  • 11.2.4 Ceva
  • 11.2.5 Elanco
  • 11.2.6 HIPRA
  • 11.2.7 Immucell Corporation
  • 11.2.8 Forte Healthcare Ltd
  • 11.2.9 Virbac
  • 11.2.10 Heilsaa